North America Pacemakers Market

Historic Data: 2016-2017   |   Base Year: 2018   |    Forecast Period: 2019-2027

Analysis and Forecasts By Product Type (Implantable Pacemakers, External Pacemakers) By Technology (Single Chambered, Dual Chambered, and Bi-Ventricular), By End User (Hospitals, Ambulatory Surgical Centers, and Others), and Country


No. of Pages: 137  |  Report Code: TIPRE00005754  |  Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Pacemakers Market

The North America pacemakers market is expected to reach US$ 5,144.2 Mn in 2027 from US$ 2,607.1 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2019-2027.

 

Key factors that are driving the growth of the market are rising incidence of cardiovascular diseases, significant geriatric population present in the region that is susceptible to the risk of chronic heart diseases and presence of key players in the market and major technological advancements made by the North American players in the market.

 

Cardiovascular diseases represent a class of multiple diseases related to blood vessels and heart. According to the World Health Organization 2017, approximately 90% of cardiovascular diseases are preventable. The WHO also states that CVD is the leading cause of death in US and worldwide. In 2017, according to the World health organization, the increasing prevalence of cardiovascular diseases is the major cause of death all over the world. Cardiovascular disease is one of the leading causes of morbidity and mortality and is responsible for 30% of worldwide mortality, according to the World Health Organization. Moreover, according to the Centers of Disease Control and Prevention, Coronary heart disease (CHD) is the most common type of heart disease, killing over 370,000 people annually. Furthermore, according to the American Heart Association, in 2016, Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease in the US, followed by stroke (16.9%), High Blood Pressure (9.8%), Heart Failure (9.3%), diseases of the arteries (3.0%), and other cardiovascular diseases (17.7%). Thus, such a high prevalence of cardiovascular diseases globally is anticipated to lead the market growth in the coming years.

 

The pacemakers market, based on product type, is segmented into implantable pacemakers and external pacemakers. In 2018, the implantable pacemakers segment held the largest share of the market, by product type. Moreover, the same segment of pacemakers market is also expected to witness growth in its demand at the fastest CAGR of 8.3% from 2019 to 2027. The spurring adoption of these devices relies majorly on the availability of reimbursement that results in reducing the economic burden on the patients in the developed economies that have a high prevalence of cardiovascular diseases. Moreover, the implantable pacemakers are highly penetrated in the market and thus are adopted as a first preference due to low risk, and other advantages offered by these devices.

NORTH AMERICA PACEMAKERS– MARKET SEGMENTATION

By Product Type

  • Implantable Pacemakers
  • External Pacemakers

By Technology

  • Single Chambered
  • Dual Chambered
  • Bi-Ventricular

By

End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Country

  • U.S
  • Canada
  • Mexico

 

Companies Mentioned

  • Medico S.p.A.
  • Vitatron
  • Abbott
  • Medtronic
  • OSCOR
  • LivaNova Plc
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik
  • Lepu Medical

North America Pacemakers Strategic Insights

Strategic insights for the North America Pacemakers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/north-america-pacemakers-market-strategic-framework.webp
Get more information on this report

North America Pacemakers Report Scope

Report Attribute Details
Market size in 2018 US$ 2,607.1 Million
Market Size by 2027 US$ 5,144.2 Million
Global CAGR (2019 - 2027) 8.0%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product Type
  • Implantable Pacemakers
  • External Pacemakers
By Technology
  • Single Chambered
  • Dual Chambered
  • Bi-Ventricular
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Medico S.p.A.
  • Vitatron
  • Abbott
  • Medtronic
  • OSCOR
  • LivaNova Plc
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik
  • Lepu Medical
Get more information on this report

North America Pacemakers Regional Insights

The geographic scope of the North America Pacemakers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/north-america-pacemakers-market-geography.webp
Get more information on this report

The List of Companies - North America Pacemakers Market

The List of Companies

 

  1. Medico S.p.A.
  2. Vitatron
  3. Abbott
  4. Medtronic
  5. OSCOR
  6. LivaNova Plc
  7. Abiomed
  8. Boston Scientific Corporation
  9. Biotronik
  10. Lepu Medical

 

Frequently Asked Questions
How big is the North America Pacemakers Market?

The North America Pacemakers Market is valued at US$ 2,607.1 Million in 2018, it is projected to reach US$ 5,144.2 Million by 2027.

What is the CAGR for North America Pacemakers Market by (2019 - 2027)?

As per our report North America Pacemakers Market, the market size is valued at US$ 2,607.1 Million in 2018, projecting it to reach US$ 5,144.2 Million by 2027. This translates to a CAGR of approximately 8.0% during the forecast period.

What segments are covered in this report?

The North America Pacemakers Market report typically cover these key segments-

  • Product Type (Implantable Pacemakers, External Pacemakers)
  • Technology (Single Chambered, Dual Chambered, Bi-Ventricular)
  • End User (Hospitals, Ambulatory Surgical Centers)
  • What is the historic period, base year, and forecast period taken for North America Pacemakers Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pacemakers Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in North America Pacemakers Market?

    The North America Pacemakers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medico S.p.A.
  • Vitatron
  • Abbott
  • Medtronic
  • OSCOR
  • LivaNova Plc
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik
  • Lepu Medical
  • Who should buy this report?

    The North America Pacemakers Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Pacemakers Market value chain can benefit from the information contained in a comprehensive market report.